MARKET

CFRX

CFRX

ContraFect
NASDAQ

Real-time Quotes | Nasdaq Last Sale

1.100
-0.020
-1.79%
Closed 16:00 01/24 EST
OPEN
1.130
PREV CLOSE
1.120
HIGH
1.150
LOW
1.060
VOLUME
1.22M
TURNOVER
--
52 WEEK HIGH
1.340
52 WEEK LOW
0.2693
MARKET CAP
168.65M
P/E (TTM)
25.00
1D
5D
1M
3M
1Y
5Y

Buy or sell shares of CFRX and other stocks commission-free!

Open a Webull account and fund it to get a free stock

Analyst Rating

Based on 2 analysts

Strong Buy

Disclaimer: The analysis information is for reference only and does not constitute an investment recommendation.

EPS

CFRX News

  • ContraFect to Present at 2020 ASM Biothreats
  • GlobeNewswire.3d ago
  • CFRX: Phase 3 DISRUPT Trial Underway
  • Zacks Small Cap Research.4d ago
  • The Daily Biotech Pulse: PhaseBio To Buy Hypertension Asset, Stemline Falls On Q4 Pre-Announcement, FDA Panel To Review Nektar's Opioid Drug
  • Benzinga.01/14 12:55
  • ACST, ADAP, SSI and VBIV among midday movers
  • Seeking Alpha - Article.01/13 17:39

More

Industry

Biotechnology & Medical Research
-2.64%
Pharmaceuticals & Medical Research
-2.00%

Hot Stocks

Name
Price
%Change

About CFRX

ContraFect Corporation is a clinical-stage biotechnology company. The Company is focused on discovering and developing therapeutic protein and antibody products for the treatment of infectious diseases, including those caused by drug-resistant pathogens, particularly those treated in hospital settings. Its pipeline of lysin candidates includes CF-301, CF-302, CF-303, CF-309, CF-304, CF-305, CF-306, CF-307 and CF-308. Its other product candidate includes CF-404. Its lysin product candidate, CF-301 is developed for the treatment of Staph aureus bacteremia, including endocarditis, caused by methicillin-resistant Staph aureus and susceptible Staph aureus strains. Its product candidate, CF-404 is used for the treatment of human influenza, including seasonal and pandemic varieties. It focuses on addressing drug-resistant infections using product candidates from its lysin and monoclonal antibody platforms that target conserved regions of either bacteria or viruses.
More

Webull offers ContraFect Corp (CFRX) stock price, real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, stock news, and many more online research tools to help you make informed decisions.